MedLumics, a medical imaging diagnostics company specializing in advanced optical coherence tomography (OCT) technology, has closed a 3.5 million euro ($4.7 million U.S.) round of Series A financing.
The funds will be used to conclude the progress of the company's imaging diagnostic platform and for technical and executive team recruitment, according to MedLumics.
MedLumics' platform integrates all OCT components in a compressed system based on a microchip, reducing production and maintenance costs compared with first-generation OCT systems, according to the company.
MedLumics said it will initially target dental implantology and intravascular imaging with this technology.
